Late benefits 10-18 years after drug therapy for infection with Schistosoma haematobium in Kwale District, Coast Province, Kenya.

Ouma, John H; King, Charles H; Muchiri, Eric M; Mungai, Peter; Koech, Davy K; Ireri, Edmund; Magak, Philip; Kadzo, Hilda

Ouma, John H; King, Charles H; Muchiri, Eric M; Mungai, Peter; Koech, Davy K; Ireri, Edmund; Magak, Philip; Kadzo, Hilda.

Affiliation

Ouma JH; Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya.

Am J Trop Med Hyg ; 73(2): 359-64, 2005 Aug.

Article in En | MEDLINE | ID: mdl-16103604

Subject(s)

Anthelmintics/therapeutic use; Schistosomiasis haematobia/drug therapy; Schistosomiasis haematobia/physiopathology; Adult; Animals; Anthelmintics/administration & dosage; Female; Follow-Up Studies; Hematuria/epidemiology; Humans; Kenya/epidemiology; Kidney Diseases/epidemiology; Male; Prevalence; Schistosoma haematobium/drug effects; Schistosomiasis haematobia/epidemiology; Schistosomiasis haematobia/parasitology; Time Factors; Treatment Outcome; Urinary Bladder Diseases/epidemiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schistosomiasis haematobia / Anthelmintics Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Am J Trop Med Hyg Year: 2005 Type: Article Affiliation country: Kenya

Search on Google

XML

PubMed Links